218 related articles for article (PubMed ID: 25454393)
1. An increased B-type natriuretic peptide in the absence of a cardiac abnormality identifies those whose left ventricular mass will increase over time.
Nadir MA; Gandy S; Ireland S; MacDonald T; Dow E; Houston G; Lang C; Struthers A
JACC Heart Fail; 2015 Jan; 3(1):87-93. PubMed ID: 25454393
[TBL] [Abstract][Full Text] [Related]
2. Serum B-type natriuretic peptide does not increase with higher systolic blood pressure in obese men despite evidence of blood pressure-related increases in left ventricular mass and filling pressure.
Asferg CL; Andersen UB; Linneberg A; Hedley PL; Christiansen M; Goetze JP; Jeppesen JL
Peptides; 2020 Dec; 134():170390. PubMed ID: 32882353
[TBL] [Abstract][Full Text] [Related]
3. NT-proBNP Predicts Cardiovascular Death in the General Population Independent of Left Ventricular Mass and Function: Insights from a Large Population-Based Study with Long-Term Follow-Up.
Dietl A; Stark K; Zimmermann ME; Meisinger C; Schunkert H; Birner C; Maier LS; Peters A; Heid IM; Luchner A
PLoS One; 2016; 11(10):e0164060. PubMed ID: 27711172
[TBL] [Abstract][Full Text] [Related]
4. Relationships Between Left Ventricular Structure and Function According to Cardiac MRI and Cardiac Biomarkers in End-Stage Renal Disease.
Ross BA; Wald R; Goldstein MB; Yuen DA; Leipsic J; Kiaii M; Rathe A; Deva DP; Kirpalani A; Bello OO; Graham JJ; Leong-Poi H; Connelly KA; Yan AT
Can J Cardiol; 2017 Apr; 33(4):501-507. PubMed ID: 28222921
[TBL] [Abstract][Full Text] [Related]
5. Natriuretic peptides as markers of preclinical cardiac disease in obesity.
Grandi AM; Laurita E; Selva E; Piantanida E; Imperiale D; Giovanella L; Guasti L; Venco A
Eur J Clin Invest; 2004 May; 34(5):342-8. PubMed ID: 15147331
[TBL] [Abstract][Full Text] [Related]
6. Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters.
Irzmański R; Banach M; Piechota M; Kowalski J; Barylski M; Cierniewski C; Pawlicki L
Clin Exp Hypertens; 2007 Apr; 29(3):149-64. PubMed ID: 17497342
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population.
Luchner A; Burnett JC; Jougasaki M; Hense HW; Heid IM; Muders F; Riegger GA; Schunkert H
J Hypertens; 2000 Aug; 18(8):1121-8. PubMed ID: 10954005
[TBL] [Abstract][Full Text] [Related]
8. Interrelationship between the Myocardial Mass, Fibrosis, BNP, and Clinical Outcomes in Hypertrophic Cardiomyopathy.
Miyaji Y; Iwanaga Y; Nakamura T; Yasuda M; Kawamura T; Miyazaki S
Intern Med; 2016; 55(10):1261-8. PubMed ID: 27181530
[TBL] [Abstract][Full Text] [Related]
9. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy.
Vickery S; Price CP; John RI; Abbas NA; Webb MC; Kempson ME; Lamb EJ
Am J Kidney Dis; 2005 Oct; 46(4):610-20. PubMed ID: 16183415
[TBL] [Abstract][Full Text] [Related]
10. B-type natriuretic peptide and wall stress in dilated human heart.
Alter P; Rupp H; Rominger MB; Vollrath A; Czerny F; Figiel JH; Adams P; Stoll F; Klose KJ; Maisch B
Mol Cell Biochem; 2008 Jul; 314(1-2):179-91. PubMed ID: 18461428
[TBL] [Abstract][Full Text] [Related]
11. Changes in B-type natriuretic peptide levels in hemodialysis and the effect of depressed left ventricular function.
Safley DM; Awad A; Sullivan RA; Sandberg KR; Mourad I; Boulware M; Merhi W; McCullough PA
Adv Chronic Kidney Dis; 2005 Jan; 12(1):117-24. PubMed ID: 15719344
[TBL] [Abstract][Full Text] [Related]
12. Novel Approach to Risk Stratification in Left Ventricular Non-Compaction Using A Combined Cardiac Imaging and Plasma Biomarker Approach.
Ramchand J; Podugu P; Obuchowski N; Harb SC; Chetrit M; Milinovich A; Griffin B; Burrell LM; Wilson Tang WH; Kwon DH; Flamm SD
J Am Heart Assoc; 2021 Apr; 10(8):e019209. PubMed ID: 33834849
[TBL] [Abstract][Full Text] [Related]
13. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
[TBL] [Abstract][Full Text] [Related]
14. Association of myocardial fibrosis, B-type natriuretic peptide, and cardiac magnetic resonance parameters of remodeling in chronic ischemic cardiomyopathy.
Henkel DM; Glockner J; Miller WL
Am J Cardiol; 2012 Feb; 109(3):390-4. PubMed ID: 22078219
[TBL] [Abstract][Full Text] [Related]
15. Gender differences in variables related to B-natriuretic peptide, left ventricular ejection fraction and mass, and peak oxygen consumption, in patients with heart failure.
Tasevska-Dinevska G; Kennedy LM; Cline-Iwarson A; Cline C; Erhardt L; Willenheimer R
Int J Cardiol; 2011 Jun; 149(3):364-71. PubMed ID: 20202706
[TBL] [Abstract][Full Text] [Related]
16. Serum phosphate is associated with left ventricular mass in patients with chronic kidney disease: a cardiac magnetic resonance study.
Chue CD; Edwards NC; Moody WE; Steeds RP; Townend JN; Ferro CJ
Heart; 2012 Feb; 98(3):219-24. PubMed ID: 22021416
[TBL] [Abstract][Full Text] [Related]
17. Increased Myocardial Stiffness in Patients With High-Risk Left Ventricular Hypertrophy: The Hallmark of Stage-B Heart Failure With Preserved Ejection Fraction.
Hieda M; Sarma S; Hearon CM; Dias KA; Martinez J; Samels M; Everding B; Palmer D; Livingston S; Morris M; Howden E; Levine BD
Circulation; 2020 Jan; 141(2):115-123. PubMed ID: 31865771
[TBL] [Abstract][Full Text] [Related]
18. Elevated B-type natriuretic peptide despite normal left ventricular function on rest and exercise stress echocardiography in mitral regurgitation.
Kerr AJ; Raffel OC; Whalley GA; Zeng I; Stewart RA
Eur Heart J; 2008 Feb; 29(3):363-70. PubMed ID: 18202251
[TBL] [Abstract][Full Text] [Related]
19. Inappropriateness of ventricular hypertrophy is important as a determinant of BNP but not of diastolic filling in untreated hypertensive patients.
Goda A; Nakao S; Tsujino T; Otsuka M; Matsumoto M; Yoshida C; Naito Y; Lee-Kawabata M; Ohyanagi M; Masuyama T
Hypertens Res; 2009 Oct; 32(10):916-9. PubMed ID: 19662018
[TBL] [Abstract][Full Text] [Related]
20. Long-term pattern of brain natriuretic peptide and N-terminal pro brain natriuretic peptide and its determinants in the general population: contribution of age, gender, and cardiac and extra-cardiac factors.
Luchner A; Behrens G; Stritzke J; Markus M; Stark K; Peters A; Meisinger C; Leitzmann M; Hense HW; Schunkert H; Heid IM
Eur J Heart Fail; 2013 Aug; 15(8):859-67. PubMed ID: 23568644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
